Table 4.
Analysis of risk factors for the prediction of the occurrence of acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD) in the prospective cohort.
| Cohort (n=50) | Underweight cohort BMI <25 kg/m2 (n=41) | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| BMI | 1.866 | 0.577–6.170 | 0.294 | 1.622 | 0.368–7.150 | 0.523 |
| FFMI | 1.768 | 0.584–5.349 | 0.313 | 1.418 | 0.318–6.314 | 0.647 |
| SMMI | 1.718 | 0.566–5.215 | 0.339 | 1.376 | 0.301–6.302 | 0.681 |
| FMI | 0.440 | 0.135–1.431 | 0.173 | 0.181 | 0.032–1.032 | 0.054 |
| LTF | 3.686 | 1.196–11.353 | 0.023* | 19.874 | 2.613–151.170 | 0.004** |
*
P<0.05;
**
P<0.01.
BMI – body mass index; SMMI – skeletal muscle mass index; FFMI – fat-free mass index; LTF – lean-to-fat; OR – odds ratio; CI – confidence interval.